Back to Agenda
Session 6: Part 2
Session Chair(s)
Sarah Dunnett
Medical Operations Partner, Sarah Dunnett Consulting Ltd, United Kingdom
For our final conference session, we will hear some different approaches which enrich both the progression and impact of Medical Information. Firstly, we will hear about the personal professional and collective benefits of collaborating across the Spanish Pharmaceutical Industry – we will gain an insight to some great achievements and exciting upcoming developments for Medical Information in Spain. Our second speaker will then share how a company-wide initiative to better understand the patient community and their expectations is being applied by their Medical Information service. As the conference draws to a close, our programme committee will come together to reflect on the conference learnings and how they will impact the future of Medical Information.
Speaker(s)
Angela Flores, MLIS
Medical Information Associate Director, Lilly, Germany
Advancing the profile of Medical Information through a Professional Organization: Experience in Spain
Hakan Aribas, MD
CEO and Founder, ORION Healthcare, Turkey
Committee Reflections and Vision
Michelle Bridenbaker, BSN, MBA, MS
Vice-President at MILE & Head of Global Medical Information, Recordati, Switzerland
Committee Reflections and Vision
Peter Brodbin
Director of Medical Information Effectiveness, Pfizer Ltd, United Kingdom
Committee Reflections and Vision
Marie-Luise Helmich, PHD
Head of Global Medical Information Key Markets - Global Medical Information, Sanofi, Germany
Committee Reflections and Vision
Sabine Lischka-Wittmann, DRSC
Sr. Director - Medical Information, Europe, Eli Lilly and Company, Germany
Committee Reflections and Vision
Isabelle C. Widmer, DrMed
CEO & Consultant, elytra GmbH, Switzerland
Committee Reflections and Vision
Have an account?